CD163 and non-small cell lung carcinoma: In the current study, through examining the percentages of MDSCs and CD68+CD163+M2-like macrophages, their relationships, their further changes in ionizing radiation therapy, and the cytokine profiles of NSCLC patients in radiotherapy, we provided novel insights into the role of myeloid-derived immune modulator cells in NSCLC patients during radiotherapy.